Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$84,512,985
+$17,893,578 QoQ
Shares Held
1,553,262
0.0% QoQ
Ownership
0.627%
of shares outstanding
% of Portfolio
4.08%
of 13F equity value
Holder Rank
#33
of 739 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caligan Partners LP holds $1,404,383,722 across 23 Biotechnology names. EXEL ranks #4 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
1,961,795 | $367,404,967 | |
| 2 | ABVX |
Abivax S.A.
|
1,557,924 | $207,608,952 | |
| 3 | PCVX |
Vaxcyte, Inc.
|
2,188,636 | $127,225,410 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
1,553,262 | $84,512,985 | |
| 5 | TNGX |
Tango Therapeutics, Inc.
|
2,500,103 | $78,153,219 | |
| 6 | AVTX |
Avalo Therapeutics, Inc.
|
3,163,866 | $58,468,243 | |
| 7 | XENE |
Xenon Pharmaceuticals Inc.
|
889,944 | $53,717,019 | |
| 8 | ADMA |
Adma Biologics, Inc.
|
5,725,007 | $47,918,308 |
All Filings in EXEL
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,512,985 | 1,553,262 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $66,619,407 | 1,553,262 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $68,079,473 | 1,553,262 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $63,012,649 | 1,525,730 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $67,254,178 | 1,525,730 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $56,329,951 | 1,525,730 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $50,806,809 | 1,525,730 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $39,592,693 | 1,525,730 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $34,283,153 | 1,525,730 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $26,120,322 | 1,100,730 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $21,848,412 | 910,730 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,899,450 | 910,730 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,404,050 | 910,730 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,498,500 | 850,000 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||